Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments
Short excerpt below. Click through to read at the original source.
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases.